Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Immunotherapy
  • (-) ≠ Pahl, J.H.W.
  • (-) ≠ Personalized medicine

Refine Results

Resource Type

Availability

Creation Date

Show more

Topic

Show more

Author

Show more

Language

Search results

  • RSS Feed
(73 - 96 of 135)

Pages

Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry
Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines
Colorectal cancer: A paradigmatic model for cancer immunology and immunotherapy
TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class I-low cancers
Mechanisms underlying success and failure of cancer immunotherapy
High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status
Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paper
Vulvar malignant melanoma: Pathogenesis, clinical behaviour and management: Review of the literature
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
CD20 as target for immunotherapy
Conjunctival Metastasis of a Cutaneous Melanoma
Correlates of immune and clinical activity of novel cancer vaccines
C1q potentiates DR5 agonist activity by a mixture of two DR5-specific HexaBody molecules
Hexamerization-enhanced CD37 and CD20 antibodies synergize in CDC to kill patient-derived CLL cells with unprecedented potency
Clinical aspects of immunotherapy and targeted therapy of advanced melanoma
Combinatory therapy adopting nanoparticle-based cancer vaccination with immune checkpoint blockade for treatment of post-surgical tumor recurrences
Report from the 4th European Bone Sarcoma Networking meeting: focus on osteosarcoma
The use of light in cancer immunotherapy
Linking T cell epitopes to a common linear B cell epitope: A targeting and adjuvant strategy to improve T cell responses
Targeting and exploiting cytomegalovirus for vaccine development
Relapsing/remitting type 1 diabetes
HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
Immune-based therapies in ovarian cancer

Pages